The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Collaboration - Partnership

LBIC maintains extensive collaborations at regional, national and international levels, which are essential for strengthening research infrastructure, advancing technological capabilities and maximizing scientific impact. These partnerships enable knowledge exchange, shared resources and coordinated development of advanced imaging methods across disciplines.

Regional Partnerships

Region Skåne

At the regional level, Region Skåne is a key strategic partner, providing vital support for both clinical and preclinical imaging facilities. This collaboration ensures close integration between research infrastructure and healthcare environments, facilitating translational research and accelerating the path from scientific discovery to clinical application. 

During 2025, LBIC further strengthened this partnership by signing new collaboration agreements with the Department of Imaging and Function (VO BoF) within Region Skåne, reinforcing the long-term framework for joint development, resource sharing and clinical–academic collaboration.

  • The National 7T MR Facility: This facility is operated in close collaboration with the Department of Imaging and Function (VO BoF) within Region Skåne. BoF continues to finance the operational expenses, including a significant portion of radiographer salaries. Additionally, BoF provides essential infrastructure for MR safety investigations, patient flow management, data security and IT support. The collaboration extends to diagnostic imaging with direct clinical impact, particularly for epilepsy patients where conventional MR imaging has been insufficient, and for cases of micro-aneurysms that are not detectable through other non-invasive techniques.
  • The Clinical MRI platform: LBIC maintains a strong partnership with BoF for the operation of clinical MR systems. These machines, owned and maintained by BoF, are housed within their facilities. LBIC previously co-financed one of the 3T MR scanners under a financial agreement. A signed collaboration agreement now governs the allocation of research time on these clinical MR scanners, ensuring optimized resource utilization.
  • Microscopy platform and Laboratory Medicine & Pathology: LBIC and the Dept. of Pathology have a long-standing collaboration. All diagnostics using electron microscopy within Region Skåne is conducted using LBIC’s microscopes by LBIC personnel. A formal collaboration agreement grants the Dept of Pathology access to about 50% of LBIC’s transmission electron microscopy capacity (16 out of 30 available hours per week).
  • The cyclotron Unit, under Clinical Physiology and Nuclear Medicine collaborates closely with LBIC’s Preclinical Nuclear Medicine platform. This partnership includes safety demonstrations and research laboratory work. Additionally, when available, the cyclotron unit generously provides LBIC with clinically produced tracers.

Research infrastructures in Lund

LBIC has collaboration with several local research infrastructures, such as:

  • Centre for Translational Genomics (CTG) - LBIC Microscopy platform is supporting workflows for spatial transcriptomics and single-cell NGS performed by CTG BMC D14 staff on LBIC microscopes at BMC D11.
  • Swedish National Infrastructure for Biological Mass Spectrometry (BioMS) - Laser capture and spatial proteomics. 
  • Microscopy for Biosciences (MBIO) Platform, Faculty of Science - users with needs not covered or due to capacity constraints at one infrastructure are sent to the other infrastructure as needed.
  • Lund University infrastructure for Image Processing and Analysis (CIPA) - Due to an increased demand for visualisation services LBIC collaborate with CIPA and InfraVis, to ensure a maintained high quality of service and avoid long waiting times for users.
  • Cryo Unit - Pre-screening of sample for cryo EM is planned to be done at LBIC. Is part of the National Screening Network – CryoScreeNET.
  • The National Research Infrastructure for Data Visualisation (Infravis) - LBIC, CIPA and InfraVis collaborate to enhance user access to specialized image analysis and visualisation expertise.

National Collaborations

Nationally, LBIC collaborates with leading research infrastructures and initiatives such as MAX IV, the Wallenberg Centre for Molecular Medicine (WCMM), SciLifeLab & Wallenberg National Program for Data-Driven Life Science (DDLS) and SciLifeLab. These collaborations promote access to complementary technologies, joint research efforts and shared expertise, enabling advanced studies that extend beyond the capacity of any single institution.

MAX IV

LBIC collaborates with MAX IV through the NanoSpam project, funded by the Swedish Research Council. LBIC contributes expertise and sample preparation, enhancing the research capabilities at MAX IV.

Wallenberg Centre for Molecular Medicine (WCMM)

LBIC collaborates extensively with principal investigators affiliated with WCMM Lund. Research groups have placed equipment within LBIC’s facilities, enabling resource-sharing. This model maximizes equipment utilization while generating revenue through user fees, significantly benefiting the research community.

SciLifeLab

Following SciLifeLab’s expansion in 2021 to include Lund, Linköping, Göteborg, and Umeå, LBIC has been actively engaged in aligning infrastructure strategies. Regular meetings with site representatives focus on strengthening cooperation, optimizing technique selection for researchers, and integrating various methodologies to enhance scientific inquiry.

National Steering Committee for the 7T Facility

As a national initiative, the 7T facility collaborates with universities in Göteborg, Linköping, Umeå, Uppsala, KTH, and KI through a dedicated research board and steering committee. Research projects from these institutions continue to utilize the facility.

International Engagement

Internationally, LBIC is actively engaged in several major collaborative networks and consortia, including Euro-BioImaging, the EU-funded ILLUMINATE consortium and the UNITY project. Through these platforms, LBIC contributes to and benefits from global cooperation in medical imaging, technology development and translational research. Participation in international infrastructures ensures alignment with emerging standards, fosters innovation and increases the visibility and competitiveness of Swedish imaging research.

Collectively, these collaborations drive scientific excellence, optimize utilization of resources and expand LBIC’s impact across biomedical, technological and clinical disciplines.

EuroBioImaging Node

In 2024, LBIC became part of the Swedish EuroBioImaging node, coordinated by KTH and Sahlgrenska. This membership facilitates national and international research access to imaging technology via the EuroBioImaging web portal, while fostering site-to-site collaboration and knowledge exchange.

UNITY Project

LBIC’s collaboration with King’s College London and the Bill & Melinda Gates Foundation within the UNITY project (Ultra-low field Neuroimaging In The Young) has progressed according to plan throughout 2025.

Nordic 7T MR Network

A Nordic 7T MR network has been established, connecting facilities in Denmark and Norway. This collaboration focuses on MR safety and method development, with the inaugural meeting held in 2022.

International 7T Collaborations

Through the National 7T MR Facility, LBIC maintains active collaborations with research centers in Copenhagen, Amsterdam, Utrecht, Leiden, and Baltimore. 

ILLUMINATE consortium

LBIC is member of the IHI-funded ILLUMINATE consortium, which aims to develop metabolic imaging techniques for early efficacy assessment of 177Lu treatment in metastatic prostate cancer. This four-and-a-half-year project, launched in November 2023, is coordinated by UMC Utrecht and involves 15 international partners.

Preclinical MRI Collaborations

The Preclinical MRI platform collaborates with King’s College London and the University of Frankfurt on projects related to automated brain segmentation and advanced diffusion MRI processing.

HALRIC Consortium

LBIC is part of the Hanseatic Life Science Research Infrastructure Consortium (HALRIC), an EU-supported initiative enhancing innovation in the Öresund- Kattegat-Skagerrak-Hamburg region. Through this collaboration there are currently two projects ongoing with LBIC staff involvement. The first project involves works with the Danish Molecular Biomedical Imaging Center (DaMBIC), and researchers at Skåne University Hospital to refine best practices, develop probe libraries, and improve data analysis workflows for spatial transcriptomics. 

In the second project, the microscopy platform aims to establish data-driven microscopy (DDM) capability at LBIC and CFIM (the Core Facility for Integrated Microscopy) at Copenhagen University together with industry partner Cytely AB. 

EATRIS - European Infrastructure for Translational Medicine

LBIC is member of EATRIS, contributing to the broader European effort to advance translational medicine through cutting-edge imaging technologies and collaborative research initiatives.

Last updated: 25 Mar 2026 | lisa [dot] karlsson [at] med [dot] lu [dot] se